Serkan Akın
Impact in
- Orthodontics top 5%
- Dental Erosion and Treatment
- Dental materials and restorations
-
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 5
- Cancer Diagnosis and Treatment 2
- HER2/EGFR in Cancer Research 2
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Kadri Altundağ (17 shared papers)Rahmiye Ertan (1 shared paper)Fikret Yılmaz (1 shared paper)Osman Gökay (1 shared paper)Meral Tunçbilek (1 shared paper)Furkan Sarici (11 shared papers)Taner Babacan (13 shared papers)Taha Koray Şahin (6 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)The Oncologist (2 papers)Journal of Clinical Medicine (2 papers)Cancer Control (2 papers)Current Problems in Cancer (1 paper)
- Partner nations
- TürkiyeUnited StatesIndia
In The Last Decade
Serkan Akın
41 papers receiving 316 citations
Peers
Comparison fields: 5 of 67
- Orthodontics 67
- Oncology 109
- Oral Surgery 24
- Cancer Research 36
- Genetics 13
Countries citing papers authored by Serkan Akın
This map shows the geographic impact of Serkan Akın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serkan Akın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serkan Akın more than expected).
Fields of papers citing papers by Serkan Akın
This network shows the impact of papers produced by Serkan Akın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serkan Akın. The network helps show where Serkan Akın may publish in the future.
Co-authors
The 25 scholars most cited alongside Serkan Akın, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 70 | |
| 2 | 2021 | 23 | |
| 3 | A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors. | 2014 | 18 |
| 4 | 2017 | 17 | |
| 5 | Molecular subtypes in patients with inflammatory breast cancer; a single center experience. | 2015 | 17 |
| 6 | 2022 | 15 | |
| 7 | Association between androgen receptor status and prognosis in triple negative breast cancer. | 2019 | 15 |
| 8 | 2022 | 14 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 8 | |
| 11 | 2015 | 8 | |
| 12 | 2024 | 7 | |
| 13 | Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats. | 2015 | 7 |
| 14 | Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. | 2016 | 7 |
| 15 | Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study. | 2020 | 7 |
| 16 | 2017 | 7 | |
| 17 | 2009 | 6 | |
| 18 | 2015 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2020 | 5 |
About Serkan Akın
Serkan Akın is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Epidemiology and Genetics, having authored 51 papers that have together received 326 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (3 papers), Vaccine Coverage and Hesitancy (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cancer Diagnosis and Treatment (2 papers), HER2/EGFR in Cancer Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Orthodontics (67 citations), Oncology (109 citations), Oral Surgery (24 citations), Cancer Research (36 citations) and Genetics (13 citations). Serkan Akın has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Kadri Altundağ, Rahmiye Ertan, Fikret Yılmaz, Osman Gökay, Meral Tunçbilek, Furkan Sarici, Taner Babacan, Taha Koray Şahin, Samer A. Srour and Deniz Can Güven. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Journal of Clinical Medicine, Cancer Control and Current Problems in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.